CVS Diagnosis and Management: AGA Provides Comprehensive Update
Conexiant
July 16, 2024
The AGA released updated guidelines for diagnosing and managing cyclic vomiting syndrome (CVS) in adults, aiming to improve recognition and treatment.
CVS affects an estimated 2% of adults in the U.S. and is characterized by recurrent episodes of intense nausea and vomiting.
The guidelines emphasize using Rome IV criteria for diagnosis and distinguishing between mild and moderate-severe CVS.
Management recommendations include lifestyle modifications, prophylactic therapy with tricyclic antidepressants, and abortive treatments during the prodromal phase.
The guidelines also address cannabis use in CVS patients and highlight the need for further research on CVS pathophysiology and clinical outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
News Staff
Affiliations:
Specialties:
Areas of Expertise: